Skip to content
Shuttingdown

Arch Therapeutics, Inc.

Surgical & Medical Instruments & Apparatus · FRAMINGHAM · MA

No longer listed

High confidence (85%)

Updated Oct 17, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: Arch Therapeutics, Inc. deregistered its securities (Jan 12, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Arch Therapeutics, Inc. deregistered its securities

    Jan 12, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 form15arch_submission010926.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54986 Exact name of registrant as specified in its charter: Arch Therapeutics, Inc. Address of principal executive offices (including zip code and telephone number): 235 Walnut Street, Suite 6, Framingham, MA 01702 (617) 431-2313…”

Company information

Founded
—
Employees (estimate)
—
Industry
Surgical & Medical Instruments & Apparatus
Subindustry
—
SEC CIK
0001537561
Website
—
LinkedIn
—
Headquarters
FRAMINGHAM, MA
Also known as
ALMAH,INC
Legal entities
Arch Therapeutics, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Arch Therapeutics, Inc. — Surgical & Medical Instruments & Apparatus (SIC 3841) — FRAMINGHAM, MA
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 form15arch_submission010926.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54986 Exact name of registrant as specified in its charter: Arch Therapeutics, Inc. Address of principal executive offices (including zip code and telephone number): 235 Walnut Street, Suite 6, Framingham, MA 01702 (617) 431-2313…
    View source record

Status history

Every derived status, with the rule that produced it.

  • NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:30 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:14 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.